These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23413276)

  • 21. Early diagnosis of acute kidney injury: the promise of novel biomarkers.
    Soni SS; Ronco C; Katz N; Cruz DN
    Blood Purif; 2009; 28(3):165-74. PubMed ID: 19590184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Update of NGAL in Acute Kidney Injury.
    Shang W; Wang Z
    Curr Protein Pept Sci; 2017; 18(12):1211-1217. PubMed ID: 27634444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Earlier diagnosis of acute kidney injury awaits effective therapy.
    Westenfelder C
    Kidney Int; 2011 Jun; 79(11):1159-61. PubMed ID: 21566636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intensive care medicine agenda on acute kidney injury.
    Pickkers P; Ostermann M; Joannidis M; Zarbock A; Hoste E; Bellomo R; Prowle J; Darmon M; Bonventre JV; Forni L; Bagshaw SM; Schetz M
    Intensive Care Med; 2017 Sep; 43(9):1198-1209. PubMed ID: 28138736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of drug-induced acute kidney injury in the adult.
    Gobe GC; Coombes JS; Fassett RG; Endre ZH
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1683-94. PubMed ID: 26548752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring treatment of acute kidney injury with damage biomarkers.
    Pianta TJ; Succar L; Davidson T; Buckley NA; Endre ZH
    Toxicol Lett; 2017 Feb; 268():63-70. PubMed ID: 28065798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel biomarkers of acute kidney injury and failure: clinical applicability.
    Mårtensson J; Martling CR; Bell M
    Br J Anaesth; 2012 Dec; 109(6):843-50. PubMed ID: 23048068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury.
    Devarajan P
    Nephrology (Carlton); 2010 Jun; 15(4):419-28. PubMed ID: 20609093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney damage biomarkers detect acute kidney injury but only functional markers predict mortality after paraquat ingestion.
    Mohamed F; Buckley NA; Jayamanne S; Pickering JW; Peake P; Palangasinghe C; Wijerathna T; Ratnayake I; Shihana F; Endre ZH
    Toxicol Lett; 2015 Sep; 237(2):140-50. PubMed ID: 26071311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular phenotyping of clinical AKI with novel urinary biomarkers.
    Huen SC; Parikh CR
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F406-13. PubMed ID: 26084933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute kidney injury (AKI).
    Antonucci E; Lippi G; Ticinesi A; Pigna F; Guida L; Morelli I; Nouvenne A; Borghi L; Meschi T
    Acta Biomed; 2014 Dec; 85(3):289-94. PubMed ID: 25567470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to use biomarkers efficiently in acute kidney injury.
    Lameire NH; Vanholder RC; Van Biesen WA
    Kidney Int; 2011 May; 79(10):1047-50. PubMed ID: 21527944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations.
    Keir I; Kellum JA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):200-9. PubMed ID: 25845505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers for acute kidney injury in critically ill patients.
    Gonzalez F; Vincent F
    Minerva Anestesiol; 2012 Dec; 78(12):1394-403. PubMed ID: 23032924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Study of the Timing and Accuracy of Neutrophil Gelatinase-Associated Lipocalin Levels in Predicting Acute Kidney Injury in High-Risk Cardiac Surgery Patients.
    Fanning N; Galvin S; Parke R; Gilroy J; Bellomo R; McGuinness S
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):76-81. PubMed ID: 26603784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.
    Mehta RL
    Nephrol Dial Transplant; 2017 Mar; 32(3):419-422. PubMed ID: 28375506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of urinary midkine as a biomarker in patients with acute kidney injury.
    Hayashi H; Sato W; Kosugi T; Nishimura K; Sugiyama D; Asano N; Ikematsu S; Komori K; Nishiwaki K; Kadomatsu K; Matsuo S; Maruyama S; Yuzawa Y
    Clin Exp Nephrol; 2017 Aug; 21(4):597-607. PubMed ID: 27530994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.